Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Ophthalmology

  Free Subscription


Articles published in Surv Ophthalmol

Retrieve available abstracts of 280 articles:
HTML format



Single Articles


    July 2026
  1. BANSAL AA, Sachdeva V, Kekunnaya R
    Infection post strabismus surgery: A review and case series.
    Surv Ophthalmol. 2026;71:1225-1235.
    PubMed     Abstract available


  2. SUNG J, Midorikawa-Inomata A, Fujio K, Inomata T, et al
    Expanding the horizon of oculomics: A narrative review on the emerging roles of the anterior segment and mobile health.
    Surv Ophthalmol. 2026;71:1074-1089.
    PubMed     Abstract available


  3. ARORA K, Gupta M, Gupta H, Sikka R, et al
    MicroRNAs as biomarkers and therapeutic targets in pterygia: A systematic review with quantitative synthesis.
    Surv Ophthalmol. 2026;71:1196-1205.
    PubMed     Abstract available


  4. VARGHESE D, Abdelsalam D, Ibrahim S, Lee AG, et al
    Too much of a good thing.
    Surv Ophthalmol. 2026;71:1236-1245.
    PubMed     Abstract available


    May 2026
  5. OUYANG CMH, Fan L, Kandel H, Watson SL, et al
    Xerophthalmia and ocular manifestations of vitamin A deficiency in children in high-income countries: A systematic review.
    Surv Ophthalmol. 2026 May 22:S0039-6257(26)00073.
    PubMed     Abstract available


  6. NADIMPALLI S, Vijendran S, Bhandary SV
    Disorganization of inner retinal layers and disruption of outer retinal layers as predictors of anti-vascular endothelial growth factor treatment outcomes in diabetic macular edema: A scoping review.
    Surv Ophthalmol. 2026 May 22:S0039-6257(26)00061.
    PubMed     Abstract available


  7. ZHAO X, Wu Z, Wu S, Cui K, et al
    Multimodal artificial intelligence in retinopathy of prematurity: A comprehensive narrative review.
    Surv Ophthalmol. 2026 May 13:S0039-6257(26)00063.
    PubMed     Abstract available


  8. AHMAD N, Chaaya C, Pandiri S, Malek D, et al
    Retinopathy of prematurity: A global review of screening guidelines.
    Surv Ophthalmol. 2026 May 7:S0039-6257(26)00064.
    PubMed     Abstract available


  9. GASSAMA S, Bastelica P, Baudouin C, Labbe A, et al
    Glaucoma filtering surgery combined with phacoemulsification in the era of new aqueous humor filtration devices: A systematic review.
    Surv Ophthalmol. 2026 May 6:S0039-6257(26)00054.
    PubMed     Abstract available


  10. LI Y, Tao Y, Wu J, He Y, et al
    Dynamic regulation mechanisms of macrophages and advances in targeted therapy for corneal injury repair.
    Surv Ophthalmol. 2026 May 3:S0039-6257(26)00053.
    PubMed     Abstract available


  11. GAO J, Liu M, Liu X, Zhang M, et al
    Multi-omics panorama of glaucoma: Pathogenesis, biomarkers, and novel therapeutic strategies.
    Surv Ophthalmol. 2026 May 2:S0039-6257(26)00055.
    PubMed     Abstract available


  12. NABAVI A, Zarei M, Shome A, Rupenthal ID, et al
    Quantitative imaging for assessing uveitis activity: A comprehensive review.
    Surv Ophthalmol. 2026 May 2:S0039-6257(26)00058.
    PubMed     Abstract available


  13. PARELLADA SE, Avaiya K, Elnour KM, Armstrong ML, et al
    Assessing the 3 pillars of housing for eye and vision health outcomes: A scoping review.
    Surv Ophthalmol. 2026;71:997-1005.
    PubMed     Abstract available


  14. TAN JH, Zhao W, Ren H, Zhang BW, et al
    Comparison of the efficacy of unilateral amblyopia treatments: A systematic review and network meta-analysis.
    Surv Ophthalmol. 2026;71:960-972.
    PubMed     Abstract available


  15. MIRMOHAMMADSADEGHI A, Sadeghi E, Akbari MR, Sadeghi M, et al
    Accuracy and clinical utility of ultrasound biomicroscopy in extraocular muscle imaging: A systematic review and meta-analysis.
    Surv Ophthalmol. 2026;71:951-959.
    PubMed     Abstract available


  16. KANG S, Hsu J, Yoo SH
    Pseudophakic mini-monovision.
    Surv Ophthalmol. 2026;71:973-979.
    PubMed     Abstract available


  17. CAMPOS A, Mota C, Cruz H, Sousa JP, et al
    Pseudophakic macular edema: Review and new insights on treatment and prophylaxis.
    Surv Ophthalmol. 2026;71:817-826.
    PubMed     Abstract available


  18. WU D, Lim BX, Sundar G, Singh S, et al
    The evaluation and management of dry anophthalmic socket syndrome.
    Surv Ophthalmol. 2026;71:925-940.
    PubMed     Abstract available


  19. CICINELLI MV, Frizziero L, Sarao V, Cennamo G, et al
    Optical coherence tomography biomarkers in patients with diabetic macular edema treated with dexamethasone implants.
    Surv Ophthalmol. 2026 May 1:S0039-6257(26)00056.
    PubMed     Abstract available


  20. ZHANG XJ, Liu M, Yu M, Fung Ho EC, et al
    Efficacy, tolerability, and threshold effect of atropine eye drops for myopia control: A systematic review and dose-response meta-analysis.
    Surv Ophthalmol. 2026 May 1:S0039-6257(26)00052.
    PubMed     Abstract available


    April 2026
  21. KHANNA RK, Cui X, Wong DCS, Makam R, et al
    Omics in hereditary optic neuropathies:A systematic review of clinical studies with an integrated point of view.
    Surv Ophthalmol. 2026 Apr 28:S0039-6257(26)00059.
    PubMed     Abstract available


  22. MANKAL S, Saidkasimova S, Lim TH, Steele TWJ, et al
    Current and future applications of intraocular bioadhesives in vitreoretinal surgery.
    Surv Ophthalmol. 2026 Apr 2:S0039-6257(26)00049.
    PubMed     Abstract available


    March 2026
  23. VON DER EMDE L, Reiter GS, Mallwitz M, Jauch AS, et al
    Quantitative fundus autofluorescence in age-related macular degeneration.
    Surv Ophthalmol. 2026 Mar 31:S0039-6257(26)00051.
    PubMed     Abstract available


  24. TORRES-COSTA S, Machado S, Barbosa G, Carvalho E, et al
    Artificial intelligence in retinal vein occlusion: Current applications, challenges, and future directions.
    Surv Ophthalmol. 2026 Mar 30:S0039-6257(26)00047.
    PubMed     Abstract available


  25. SADEK K, Yu P, Butt FR, Tao BK, et al
    Anti-vascular endothelial growth factor and choroidal thickness in retinal vein occlusion: A systematic review and meta-analysis.
    Surv Ophthalmol. 2026 Mar 28:S0039-6257(26)00050.
    PubMed     Abstract available


  26. XU Q, Zhu H, Gong C
    Laboratory tests of ocular toxocariasis: From pathological diagnosis to immunological diagnosis.
    Surv Ophthalmol. 2026 Mar 24:S0039-6257(26)00048.
    PubMed     Abstract available


  27. MARTYKA A, Bolek B, Gospodarczyk N, Czuj W, et al
    Therapeutic potential of norrin/FZD4/beta-catenin signaling in blood-retinal barrier protection.
    Surv Ophthalmol. 2026 Mar 18:S0039-6257(26)00044.
    PubMed     Abstract available


  28. VERA-DUARTE GR, Ortiz-Morales G, Guerrero-Acosta JC, Carrete-Corral SA, et al
    Atopic Keratoconjunctivitis: From Molecular Mechanisms to Clinical Implications.
    Surv Ophthalmol. 2026 Mar 17:S0039-6257(26)00043.
    PubMed     Abstract available


  29. BUSZA AM, Lyons CE, Hamzeh N, Mohammadi S, et al
    Optical coherence tomography angiography in pediatric and adult populations: A comprehensive review.
    Surv Ophthalmol. 2026 Mar 11:S0039-6257(26)00042.
    PubMed     Abstract available


  30. QUARTA A, Feo A, Boscia G, Savastano A, et al
    Inner retinal surface abnormalities: Imaging phenotypes, quantitative features, and mechanistic insights across surgical and nonsurgical conditions.
    Surv Ophthalmol. 2026 Mar 11:S0039-6257(26)00038.
    PubMed     Abstract available


  31. RIZZO C, Mercuri S, Savastano MC, Govetto A, et al
    Peripheral retinal degenerations: A review of peripheral optical coherence tomography applications in their diagnosis and visualization.
    Surv Ophthalmol. 2026 Mar 11:S0039-6257(26)00040.
    PubMed     Abstract available


  32. JURKIEWICZ T, Marty AS
    William W. Cooper, and his epidemiological study "On the conical cornea" of 1850.
    Surv Ophthalmol. 2026 Mar 10:S0039-6257(26)00036.
    PubMed     Abstract available


  33. WANG IM, Tsai IL
    Comparative Pathogenesis and Management of Orbital/Conjunctival and Gastric MALT Lymphoma: Microbial Drivers, Molecular Mechanisms, and Therapeutic Implications.
    Surv Ophthalmol. 2026 Mar 10:S0039-6257(26)00041.
    PubMed     Abstract available


  34. SHEIBANI K, Bayat K, Rajavi Z, Abdi S, et al
    Ophthalmic manifestations in preterm children without retinopathy of prematurity: A review.
    Surv Ophthalmol. 2026 Mar 10:S0039-6257(26)00034.
    PubMed     Abstract available


  35. LINGHU D, Zhu X, Liang J, Cheng Y, et al
    Efficacy and safety of conbercept, ranibizumab and laser in retinopathy of prematurity: a systematic review and network meta-analysis.
    Surv Ophthalmol. 2026 Mar 6:S0039-6257(26)00035.
    PubMed     Abstract available


  36. QUARTA A, Feo A, Corradetti G, Popovic MM, et al
    Double layer sign in chorioretinal diseases: Clinical significance and implications from multimodal imaging.
    Surv Ophthalmol. 2026;71:456-466.
    PubMed     Abstract available


  37. ALBERTOS-ARRANZ H, Juvier-Riesgo T, Sainfort F, Jayakar A, et al
    A scoping review on clinical and genetic diagnostic approaches for cerebral visual impairment.
    Surv Ophthalmol. 2026;71:647-661.
    PubMed     Abstract available


  38. HUANG S, Tong JY, Juniat V, Almater A, et al
    Radiological features of lacrimal gland masses.
    Surv Ophthalmol. 2026;71:700-717.
    PubMed     Abstract available


  39. CARLA MM, Philippakis E, Gaucher D, Couturier A, et al
    Current advances in dome-shaped macula and associated conditions.
    Surv Ophthalmol. 2026;71:393-404.
    PubMed     Abstract available


  40. VENKATESH R DR, Hande P Dr, Prabhu V Dr, Vidyasagar S Dr, et al
    Dissecting the clinical and pathophysiological complexity of fundus tessellation.
    Surv Ophthalmol. 2026;71:382-392.
    PubMed     Abstract available


  41. PARMAR UPS, Arora A, Agarwal A, Gangaputra S, et al
    Detection and quantification of fluorescein angiography leakage: From manual grading to advances in machine learning.
    Surv Ophthalmol. 2026;71:613-626.
    PubMed     Abstract available


  42. NOURI H, Hasan N, Abtahi SH, Ahmadieh H, et al
    Deep learning in central serous chorioretinopathy.
    Surv Ophthalmol. 2026;71:718-748.
    PubMed     Abstract available


  43. HOOPER CY, Ferreira LB, Vaze A, Vasconcelos-Santos DV, et al
    Relentless placoid chorioretinitis.
    Surv Ophthalmol. 2026;71:467-482.
    PubMed     Abstract available


  44. CHENG JY, Hsu D, Feo A, Liu V, et al
    Chorioretinal folds: A review and update of new and old etiologies.
    Surv Ophthalmol. 2026;71:405-422.
    PubMed     Abstract available


    February 2026
  45. SIM SY, Lim LT, Chaudhary S, Musa M, et al
    Update on subthreshold micropulse laser treatment for retinal diseases: A narrative review.
    Surv Ophthalmol. 2026 Feb 26:S0039-6257(26)00022.
    PubMed     Abstract available


  46. ZHANG C, Xu Z
    Advancements of ultrasound modalities and their clinical potential in ophthalmology.
    Surv Ophthalmol. 2026 Feb 24:S0039-6257(26)00021.
    PubMed     Abstract available


  47. KORKMAZ I, Palamar M
    Complications of corneal crosslinking: What can go wrong?
    Surv Ophthalmol. 2026 Feb 24:S0039-6257(26)00023.
    PubMed     Abstract available


  48. MURATI F, Ghahari P, Zvavamwe T, Williams WW, et al
    Levodopa in retinal disease: Dopamine pathways, neuroprotective mechanisms, and clinical evidence.
    Surv Ophthalmol. 2026 Feb 24:S0039-6257(26)00024.
    PubMed     Abstract available


  49. ZIEMSSEN F, Loewenstein A, Aslam TM
    Effective communication strategies in intravitreal therapy: How to listen and how to talk to people who need injections in their eyes.
    Surv Ophthalmol. 2026 Feb 24:S0039-6257(26)00025.
    PubMed     Abstract available


  50. FERRO DESIDERI L, Fukuhara PS, Wintergerst MWM, Meyer CH, et al
    Ocular inflammation after intraocular drug delivery: Mechanisms, risk factors, and implications for clinical practice.
    Surv Ophthalmol. 2026 Feb 17:S0039-6257(26)00019.
    PubMed     Abstract available


  51. KHILJI M, Hira S, Ahmed Z, Ansar S, et al
    Safety and efficacy of anti-vascular endothelial growth factor (VEGF) plus corticosteroids versus anti-VEGF alone for macular edema from retinal vein occlusion: A systematic review and meta-analysis.
    Surv Ophthalmol. 2026 Feb 14:S0039-6257(26)00018.
    PubMed     Abstract available


  52. SUSIYANTI M, Febrina F, Putera I, Jelita A, et al
    Metagenomic sequencing in various ocular infections: A systematic review of diagnostic utility.
    Surv Ophthalmol. 2026 Feb 6:S0039-6257(26)00014.
    PubMed     Abstract available


  53. CASTRO-FERNANDEZ DC, Canizo-Outerino A, Cuartero-Martinez A, Gil-Martinez M, et al
    A systematic review on age-related macular degeneration: New insights from multi-omics studies.
    Surv Ophthalmol. 2026 Feb 3:S0039-6257(26)00016.
    PubMed     Abstract available


    January 2026
  54. GHARBI K, Wijngaarden PV, Hadoux X
    Foundation models for ophthalmic imaging.
    Surv Ophthalmol. 2026 Jan 29:S0039-6257(26)00012.
    PubMed     Abstract available


  55. HUANG L, Chen A, Zhang Q, Zhu J, et al
    Ocular frailty: A concept analysis.
    Surv Ophthalmol. 2026 Jan 28:S0039-6257(26)00013.
    PubMed     Abstract available


  56. SALH D, Pickard MR, Al-Mehiawi A, Parker R, et al
    Exploring successful treatments for upper eyelid retraction in thyroid eye disease: A scoping review.
    Surv Ophthalmol. 2026 Jan 25:S0039-6257(26)00011.
    PubMed     Abstract available


  57. LA ROSA A, Feo A, Govetto A, Rossi T, et al
    Prognostic factors after rhegmatogenous retinal detachment repair: An overview of the clinical and imaging insights.
    Surv Ophthalmol. 2026 Jan 8:S0039-6257(26)00002.
    PubMed     Abstract available


  58. NAIR S, Deshmukh R, Mohan S, Agarwal T, et al
    Corneal transplantation triple procedures.
    Surv Ophthalmol. 2026 Jan 2:S0039-6257(25)00235.
    PubMed     Abstract available


  59. HUANG A, Zhang A, Lee D, Ying GS, et al
    Placebo or vehicle effects on dry eye signs and symptoms in randomized controlled trials: A systematic review and meta-analysis.
    Surv Ophthalmol. 2026;71:207-214.
    PubMed     Abstract available


  60. VENKATESH R, Prabhu V, Hande P, Tendulkar K, et al
    Controversies and conundrums in pachychoroid spectrum disorders: A structured diagnostic approach.
    Surv Ophthalmol. 2026;71:25-34.
    PubMed     Abstract available


  61. RUGGERI ML, Romano MR, Rossi T, Bacherini D, et al
    Silicone oil removal-related vision loss.
    Surv Ophthalmol. 2026;71:61-70.
    PubMed     Abstract available


  62. CARLA MM, Giannuzzi F, Hu L, Rizzo C, et al
    The human amniotic membrane in vitreoretinal surgery: Applications, outcomes and limitations.
    Surv Ophthalmol. 2026;71:14-24.
    PubMed     Abstract available


  63. GOWDA A, Wood JPM, Chidlow G, Casson RJ, et al
    Laser-induced histopathological changes to the retina: A review.
    Surv Ophthalmol. 2026;71:53-60.
    PubMed     Abstract available


  64. ZHANG H, Li Z, Chan HC, Song X, et al
    Artificial intelligence in thyroid eye disease imaging: A systematic review.
    Surv Ophthalmol. 2026;71:142-157.
    PubMed     Abstract available


  65. SHEN Y, Frauches R, Zhao J, Lo CH, et al
    Pathophysiology of intraoperative floppy iris syndrome: An unsettled debate.
    Surv Ophthalmol. 2026;71:200-206.
    PubMed     Abstract available


    December 2025
  66. BALA S, Allan KC, Decker NL, Abbass NJ, et al
    Glucagon-like peptide-1 receptor agonists: What ophthalmologists need to know.
    Surv Ophthalmol. 2025 Dec 31:S0039-6257(25)00236.
    PubMed     Abstract available


  67. CHEN KY, Chan HC, Chan CM
    Is intra-arterial chemotherapy superior to conventional chemotherapy for retinoblastoma? A systematic review and meta-analysis of efficacy and safety.
    Surv Ophthalmol. 2025 Dec 31:S0039-6257(25)00234.
    PubMed     Abstract available


  68. LAI A, Issa M, Pereira A, Ghafri MA, et al
    Age-related choroidal atrophy: A systematic review of multimodal imaging, clinical features, and differentiation from other forms of macular degeneration.
    Surv Ophthalmol. 2025 Dec 18:S0039-6257(25)00232.
    PubMed     Abstract available


  69. CHYCHKO L, Son HS, Friedrich M, Yildirim TM, et al
    The diagnostic potential of aqueous humor: Unlocking ocular and systemic insights.
    Surv Ophthalmol. 2025 Dec 17:S0039-6257(25)00231.
    PubMed     Abstract available


  70. HOLT CA, Niedert C, Gedtal M, Virgili G, et al
    Prognostic factors for age-related macular degeneration progression: An overview of systematic reviews.
    Surv Ophthalmol. 2025 Dec 16:S0039-6257(25)00230.
    PubMed     Abstract available


  71. WANG TW, Luo WT, Tu YK, Chou YB, et al
    Prospective validation of deep-learning algorithms for diabetic retinopathy screening: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Dec 2:S0039-6257(25)00226.
    PubMed     Abstract available


  72. NABAVI A, Haddock LJ, Mahmoudi A, Salabati M, et al
    Retinal nerve fiber layer thickness as a biomarker of uveitis activity: A systematic review.
    Surv Ophthalmol. 2025 Dec 2:S0039-6257(25)00228.
    PubMed     Abstract available


  73. JAYADEV C, Tendulkar K, Vidyasagar S, Gambhir V, et al
    The downside of tamponade: Silicone oil emulsification and its ocular impact.
    Surv Ophthalmol. 2025 Dec 2:S0039-6257(25)00229.
    PubMed     Abstract available


    November 2025
  74. GRIECO G, Carla MM, Di Stefano G, Scampoli A, et al
    Updates on surgical and nonsurgical innovations for macular hole treatment.
    Surv Ophthalmol. 2025 Nov 12:S0039-6257(25)00215.
    PubMed     Abstract available


  75. PORTENY JR, Scudder P, Darlow BA, Vanderveen DK, et al
    A scoping review of adverse visual outcomes among preterm infants without, versus those with, retinopathy of prematurity.
    Surv Ophthalmol. 2025 Nov 11:S0039-6257(25)00214.
    PubMed     Abstract available


  76. RASHID M, Azeem S, Shahid IF, Ali MKB, et al
    Efficacy and safety of aflibercept biosimilars compared to reference aflibercept for retinal diseases: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Nov 11:S0039-6257(25)00213.
    PubMed     Abstract available


  77. TONG JY, Sung J, Chan W, Psaltis AJ, et al
    Transorbital endoscopic approaches: Applications in orbital surgery.
    Surv Ophthalmol. 2025 Nov 7:S0039-6257(25)00198.
    PubMed     Abstract available


  78. ZHANG C, Xia Z, Mao W, Lin Z, et al
    Optical coherence tomography angiogropahy changes in patients with diabetic retinopathy treated with panretinal photocoagulation: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Nov 7:S0039-6257(25)00196.
    PubMed     Abstract available


  79. FEO A, Tailor PD, Au A, Wu A, et al
    Anterior segment optical coherence tomography in uveitis: A comprehensive review of clinical applications, diagnostic insights, and future directions.
    Surv Ophthalmol. 2025 Nov 5:S0039-6257(25)00197.
    PubMed     Abstract available


  80. BAYAT K, Pooyan P, Feizi S, Ahmadieh H, et al
    Structural alterations in the retina and choroid of keratoconus patients detected by optical coherence tomography: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Nov 4:S0039-6257(25)00195.
    PubMed     Abstract available


  81. APHALE P, Shekhar H, Dokania S
    Comments on "Refining the translational pathway for senotherapeutics in age-related macular degeneration: Insights on biomarkers, delivery strategies, and clinical trial design".
    Surv Ophthalmol. 2025 Nov 3:S0039-6257(25)00191.
    PubMed    


  82. CHEN KY, Chan HC, Chan CM
    Response letter to "Effectiveness and safety of anti-vascular endothelial growth factor therapies for macular edema in retinal vein occlusion: Correspondence".
    Surv Ophthalmol. 2025 Nov 2:S0039-6257(25)00189.
    PubMed    


  83. BHATTI MT, Moore JG, Hwang TN, Bilyk JR, et al
    Blow.
    Surv Ophthalmol. 2025;70:1261-1266.
    PubMed     Abstract available


  84. COUTURIER A, Wykoff CC, Lupidi M, Udaondo P, et al
    Anatomic biomarkers as potential endpoints in diabetic macular edema: A systematic literature review with identification of macular volume as a key surrogate for visual acuity.
    Surv Ophthalmol. 2025;70:1090-1110.
    PubMed     Abstract available


  85. ZHANG P, Xu Z
    The advancements in precision medicine for Leber congenital amaurosis: Breakthroughs from genetic diagnosis to therapy.
    Surv Ophthalmol. 2025;70:1205-1219.
    PubMed     Abstract available


  86. LEE SH, Ho YR, Li H, Tu YK, et al
    Prevalence and clinical manifestations of cytomegalovirus infection in patients with Posner-Schlossman syndrome: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025;70:1252-1260.
    PubMed     Abstract available


    October 2025
  87. DAUNGSUPAWONG H, Wiwanitkit V
    Effectiveness and safety of anti-vascular endothelial growth factor therapies for macular edema in retinal vein occlusion: Correspondence.
    Surv Ophthalmol. 2025 Oct 29:S0039-6257(25)00192.
    PubMed    


  88. DEIMAZAR G, Sabbaghi H, Ahmadieh H, Sheikhtaheri A, et al
    Artificial intelligence for detection of age-related macular degeneration based on fundus images: A systematic review.
    Surv Ophthalmol. 2025 Oct 29:S0039-6257(25)00193.
    PubMed     Abstract available


  89. CHEN Y, Jiang F, Zhang M
    Response to Comments on Refining the translational pathway for senotherapeutics in age-related macular degeneration: Insights on biomarkers, delivery strategies, and clinical trial design.
    Surv Ophthalmol. 2025 Oct 28:S0039-6257(25)00190.
    PubMed    


  90. NUSAIR O, Soleimani M
    Additional observations on ROCK inhibitors: Reticular corneal epithelial edema.
    Surv Ophthalmol. 2025 Oct 3:S0039-6257(25)00187.
    PubMed    


  91. PARIS JE, Macri CZ, Lee YM, Chan WO, et al
    Retinal imaging options for differentiating degenerative retinoschisis from retinal detachment: A scoping review.
    Surv Ophthalmol. 2025 Oct 3:S0039-6257(25)00145.
    PubMed     Abstract available


  92. HENEIN C, Tan JK, Steel DH, Ahmad S, et al
    Response to "Additional observations on ROCK inhibitors: reticular corneal epithelial edema".
    Surv Ophthalmol. 2025 Oct 3:S0039-6257(25)00186.
    PubMed    


  93. LIU Y, Gong D, Dang K, Guo J, et al
    Diagnostic accuracy of next generation sequencing--based genetic research for primary glaucoma: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Oct 1:S0039-6257(25)00181.
    PubMed     Abstract available


  94. TAO BK, Hwang J, Park S, Mikhail D, et al
    Prefilled syringes and post-intravitreal injection endophthalmitis: A network meta-analysis.
    Surv Ophthalmol. 2025 Oct 1:S0039-6257(25)00184.
    PubMed     Abstract available


  95. GHALIBAFAN S, Herskowitz WR, Chou BG, Rohowetz LJ, et al
    Isolated tattoo-associated uveitis without systemic sarcoidosis: A systematic review of case reports.
    Surv Ophthalmol. 2025 Oct 1:S0039-6257(25)00183.
    PubMed     Abstract available


  96. MERLE DA, Beretta F, Sacconi R, Querques G, et al
    Fibrogliosis in neovascular age-related macular degeneration: A new mechanistic perspective.
    Surv Ophthalmol. 2025 Oct 1:S0039-6257(25)00185.
    PubMed     Abstract available


  97. FEIZI S, Hatami F, Mirzaei SK, Bayat K, et al
    Medical and surgical approaches to prevent corneal graft rejection in high-risk recipients.
    Surv Ophthalmol. 2025 Oct 1:S0039-6257(25)00182.
    PubMed     Abstract available


    September 2025
  98. ESHRAGHI B, Babaei L, Aghajani A
    Altered ocular surface microbiome in nasolacrimal duct obstruction: Clinical Implications for intraocular surgery.
    Surv Ophthalmol. 2025 Sep 22:S0039-6257(25)00178.
    PubMed     Abstract available


  99. TSENG YH, Wu PL, Kang EY, Chen KJ, et al
    Advancements in ocular blood flow imaging: Clinical applications of laser speckle flowgraphy and optical coherence tomography angiography in retinal and choroidal vascular diseases.
    Surv Ophthalmol. 2025 Sep 21:S0039-6257(25)00180.
    PubMed     Abstract available


  100. SABOYA-GALINDO P, Cifuentes-Gonzalez C, Rojas-Carabali W, Mejia-Salgado G, et al
    Clinical trials and quasi-experimental studies in the treatment of noninfectious retinal vasculitis: A Systematic Review from the International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) - Report 4.
    Surv Ophthalmol. 2025 Sep 20:S0039-6257(25)00173.
    PubMed     Abstract available


  101. LEE E, Hunt D, Cakir Y, Kuo D, et al
    Artificial intelligence in age-related macular degeneration: Advancing diagnosis, prognosis, and treatment.
    Surv Ophthalmol. 2025 Sep 18:S0039-6257(25)00174.
    PubMed     Abstract available


  102. SUGANYA DEVI K, Vasireddi HK, Reddy GR, Satti SK, et al
    Unfolding the diagnostic pipeline of diabetic retinopathy with artificial intelligence: A systematic review.
    Surv Ophthalmol. 2025 Sep 17:S0039-6257(25)00170.
    PubMed     Abstract available


  103. CIFUENTES-GONZALEZ CG, Putera I, Walter CFY, Mejia-Salgado MS, et al
    Work-up in patients with retinal vasculitis: A systematic review and meta-analysis: International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) Report 2.
    Surv Ophthalmol. 2025 Sep 17:S0039-6257(25)00175.
    PubMed     Abstract available


  104. LA ROSA A, Feo A, Bousquet E, Cabral D, et al
    Angioid streaks-related choroidal neovascularization: Clinical features, multimodal imaging-based differential diagnosis, and optimized treatment strategies.
    Surv Ophthalmol. 2025 Sep 17:S0039-6257(25)00169.
    PubMed     Abstract available


  105. NANJI K, Hatamnejad A, Grad J, El-Sayes A, et al
    Visual outcomes associated with optical coherence tomography biomarkers in diabetic macular edema: A systematic review.
    Surv Ophthalmol. 2025 Sep 17:S0039-6257(25)00176.
    PubMed     Abstract available


  106. KOCAK I, Sayin N, Bayramoglu SE, Thalib L, et al
    Effect of methotrexate in preventing retinal detachment after proliferative vitreoretinopathy surgery: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Sep 16:S0039-6257(25)00177.
    PubMed     Abstract available


  107. SUMODHEE D, Ioannidou E, Ramessur R, Prashar J, et al
    Interventions to improve patients' knowledge in ophthalmology: A systematic review and narrative synthesis.
    Surv Ophthalmol. 2025 Sep 13:S0039-6257(25)00168.
    PubMed     Abstract available


  108. LOH NC, Rojas-Carabali W, Lim YH, Bong JE, et al
    Choroidal Vascularity Index as a marker of health and disease: Systematic review and meta-Analyses.
    Surv Ophthalmol. 2025 Sep 5:S0039-6257(25)00164.
    PubMed     Abstract available


  109. HATAMNEJAD A, Nanji K, Grad J, El-Sayes A, et al
    Predicting Treatment Response in Retinal Vein Occlusions Using Baseline Optical Coherence Tomography Biomarkers: A Systematic Review.
    Surv Ophthalmol. 2025 Sep 4:S0039-6257(25)00148.
    PubMed     Abstract available


  110. SONG W, Chen W, Chi J, Liu X, et al
    The role of lipid metabolism disorder in the progression and treatment of ocular vascular diseases.
    Surv Ophthalmol. 2025 Sep 4:S0039-6257(25)00163.
    PubMed     Abstract available


  111. LIU C, Yan R, Jiang J
    Adjustable suture versus nonadjustable suture surgery for childhood strabismus: A meta-analysis.
    Surv Ophthalmol. 2025;70:859-867.
    PubMed     Abstract available


  112. CARLA MM, Ripa M, Crincoli E, Catania F, et al
    The spectrum of microcystic macular edema: Pathogenetic insights, clinical entities, and functional prognosis.
    Surv Ophthalmol. 2025;70:982-994.
    PubMed     Abstract available


  113. JEAN-CHARLES S, Shoji MK, Kikkawa DO, Bhatti MT, et al
    The mirrored arterial dilemma.
    Surv Ophthalmol. 2025;70:1029-1033.
    PubMed     Abstract available


    August 2025
  114. GIANNOPOULOS NG, Macri CZ, Seneviratne IAK, Bacchi S, et al
    A narrative review of the psychological impact of intravitreal injections.
    Surv Ophthalmol. 2025 Aug 28:S0039-6257(25)00144.
    PubMed     Abstract available


  115. MOZAFAR M, Fekrazad S, Amanollahi M, Samiee R, et al
    Optical coherence tomography angiography measurements in thyroid eye disease: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Aug 20:S0039-6257(25)00143.
    PubMed     Abstract available


  116. MALOOF AG, Zhang S, Pavic NV, Coroneo MT, et al
    'Seeing both sides': A systematic review of the Miyake-Apple video system's role in Ophthalmology.
    Surv Ophthalmol. 2025 Aug 20:S0039-6257(25)00134.
    PubMed     Abstract available


  117. QIAN Y, Lin X, Wang Y, Mao Y, et al
    In vivo detection of macrophage-like cells at the vitreoretinal interface in retinal diseases using optical coherence tomography angiography.
    Surv Ophthalmol. 2025 Aug 19:S0039-6257(25)00141.
    PubMed     Abstract available


  118. LE NVA, Nguyen NC, Kasetsuwan N, Reinprayoon U, et al
    Corrigendum to "Penetrating keratoplasty versus deep anteriror lamellar keratoplasty for macular corneal dystrophy: A meta-analysis" [Survey Ophthalomol., vol. 70 (2025) P480-488/ PMID: 39709033].
    Surv Ophthalmol. 2025 Aug 18:S0039-6257(25)00137.
    PubMed    


  119. SEN M, Munier FL, Honavar SG
    Intraocular seeds in retinoblastoma: A review of classification, management, and outcomes.
    Surv Ophthalmol. 2025 Aug 15:S0039-6257(25)00139.
    PubMed     Abstract available


  120. RAJESWAREN V, Trivedi V, Yoganathan P
    Macular hole after anti-Vascular Endothelial Growth factor injection: A review.
    Surv Ophthalmol. 2025 Aug 14:S0039-6257(25)00140.
    PubMed     Abstract available


  121. PARIS JE, Macri CZ, Lake SR, Chan WO, et al
    Risk factors for retinal breaks following surgical induction of posterior vitreous detachment: A scoping review.
    Surv Ophthalmol. 2025 Aug 12:S0039-6257(25)00138.
    PubMed     Abstract available


  122. DIRANI K, Kim C, Park J, Gregory A, et al
    Clinical Implications of heavy silicon oil (Densiron(R)) endotamponade after pars plana vitrectomy: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Aug 7:S0039-6257(25)00132.
    PubMed     Abstract available


  123. GAO J, Wang W, Mo Y
    Retinal Degenerative Diseases: Complement system-Microglia Crosstalk.
    Surv Ophthalmol. 2025 Aug 5:S0039-6257(25)00135.
    PubMed     Abstract available


    July 2025
  124. HE M, Yang Z, Shi Z, Chen Y, et al
    Clinical features, management, and prognosis factors of traumatic optic neuropathy.
    Surv Ophthalmol. 2025 Jul 30:S0039-6257(25)00129.
    PubMed     Abstract available


  125. CARLA MM, Mottola F, Cusato M, Oreste G, et al
    Vitreoretinal interface abnormalities in age-related macular degeneration: Prevalence, pathophysiology, and reciprocal influence.
    Surv Ophthalmol. 2025 Jul 23:S0039-6257(25)00126.
    PubMed     Abstract available


  126. DRAKOPOULOS M, Nadel A, Bains HK, Bisen JB, et al
    Quantitative ophthalmic posterior segment optical coherence tomography angiography and systemic conditions.
    Surv Ophthalmol. 2025 Jul 21:S0039-6257(25)00123.
    PubMed     Abstract available


  127. ZHANG HY, Smith AW, Laferriere HE, Finn AP, et al
    The use of time-driven activity-based costing in ophthalmology: A scoping review.
    Surv Ophthalmol. 2025 Jul 19:S0039-6257(25)00122.
    PubMed     Abstract available


  128. JIN K, Yu T, Grzybowski A
    Multimodal artificial intelligence in ophthalmology: Applications, challenges, and future directions.
    Surv Ophthalmol. 2025 Jul 17:S0039-6257(25)00120.
    PubMed     Abstract available


  129. SUH A, Szeto JJ, Ong J, Armstrong GW, et al
    Ocular trauma in microgravity: In-flight diagnostics and extraterrestrial strategies for management.
    Surv Ophthalmol. 2025 Jul 15:S0039-6257(25)00124.
    PubMed     Abstract available


  130. CARLA MM, Couturier A, Mottola F, Cusato M, et al
    The influence of scleral buckle on choroidal architecture: An unexplored link with the spectrum of acquired overload choroidopathy?
    Surv Ophthalmol. 2025 Jul 9:S0039-6257(25)00108.
    PubMed     Abstract available


  131. WAN Y, Guo X, Wang N
    Trabecular meshwork: A pivotal target for evolving glaucoma treatments.
    Surv Ophthalmol. 2025 Jul 8:S0039-6257(25)00107.
    PubMed     Abstract available


  132. VILARES-MORGADO R, Verbruggen K, Stalmans I, Barbosa-Breda J, et al
    Age-related changes in optical coherence tomography glaucoma-related parameters: A systematic review.
    Surv Ophthalmol. 2025 Jul 3:S0039-6257(25)00104.
    PubMed     Abstract available


  133. KHOSRAVI MIRZAEI S, Hatami F, Safi S, Khorrami Z, et al
    Pharmacological agents for treatment of proliferative vitreoretinopathy: A systematic review and network meta-analysis.
    Surv Ophthalmol. 2025;70:633-644.
    PubMed     Abstract available


  134. JAIN M, Mohankumar A, Torres J, Alkorbi HA, et al
    Pharmacological associations of central serous chorioretinopathy: Looking beyond corticosteroids.
    Surv Ophthalmol. 2025;70:616-632.
    PubMed     Abstract available


  135. ARRUDA MP, Hira S, Lima RV, Barbosa LIT, et al
    Pharmacological therapy for relieving pain in panretinal photocoagulation: A network meta-analysis of randomized controlled trials.
    Surv Ophthalmol. 2025;70:645-652.
    PubMed     Abstract available


  136. SHETH JU, Stewart MW, Narayanan R, Anantharaman G, et al
    Macular neovascularization.
    Surv Ophthalmol. 2025;70:653-675.
    PubMed     Abstract available


  137. WOUDSTRA-DE JONG JE, Busschbach JJ, Manning-Charalampidou SS, Vingerling JR, et al
    Assessment of patient-reported outcomes in vitreomacular interface disorders: A systematic literature review.
    Surv Ophthalmol. 2025;70:685-694.
    PubMed     Abstract available


  138. MELENDEZ-MORENO A, Yesiltas YS, Jacquelyn Wrenn NP, Singh AD, et al
    Corrigendum to "Iris melanoma: Prognostication for metastasis"[Survey Ophthalmol 68 (2023) 957-963].
    Surv Ophthalmol. 2025 Jul 1:S0039-6257(25)00106.
    PubMed    


    June 2025
  139. SONG A, Lee E, Ostmo SR, Jonas KE, et al
    Retinopathy of prematurity training and education: A systematic review.
    Surv Ophthalmol. 2025 Jun 18:S0039-6257(25)00102.
    PubMed     Abstract available


  140. VON DER EMDE L, Petzinna SM, Herwig-Carl MC, Adamson MS, et al
    Advances in diagnosing and treating giant cell arteritis: New hope for arteritic anterior ischemic optic neuropathy.
    Surv Ophthalmol. 2025 Jun 18:S0039-6257(25)00103.
    PubMed     Abstract available


  141. YANG WYL, Wong HJ, Fu CE, Rojas-Carabali W, et al
    Artificial intelligence in the prediction of glaucoma development and progression: A systematic review.
    Surv Ophthalmol. 2025 Jun 18:S0039-6257(25)00105.
    PubMed     Abstract available


  142. HAMMOUD B, Schumacher JS, Zhang H, Dutra BAL, et al
    Brillouin microscopy for focal biomechanical measurements in normal and keratoconic corneas: A narrative review.
    Surv Ophthalmol. 2025 Jun 11:S0039-6257(25)00099.
    PubMed     Abstract available


  143. TOVEY CRUTCHFIELD EC, Vincent AL, Anjou MD, Taylor HR, et al
    Inherited retinal disease in global Indigenous populations: A scoping review.
    Surv Ophthalmol. 2025 Jun 11:S0039-6257(25)00101.
    PubMed     Abstract available


  144. WOO J, Chopra S, Liu K, Tuttle B, et al
    Impact of neighborhood-level deprivation on glaucoma prevalence and treatment: A review of the literature.
    Surv Ophthalmol. 2025 Jun 10:S0039-6257(25)00100.
    PubMed     Abstract available


  145. HAN L, Mao Y, Sang Q, Wan Y, et al
    Efficacy and complications of microcatheter-assisted minimally invasive glaucoma surgery for open-angle glaucoma: A systematic review and network meta-analysis.
    Surv Ophthalmol. 2025 Jun 6:S0039-6257(25)00097.
    PubMed     Abstract available


    May 2025
  146. ALKHABAZ A, Pujari R, Ren Y, Smith SJ, et al
    Optic disc drusen-associated neovascularization: A systematic review.
    Surv Ophthalmol. 2025 May 27:S0039-6257(25)00095.
    PubMed     Abstract available


  147. CHEN KY, Chan HC, Chan CM
    Effectiveness and safety of anti-vascular endothelial growth factor therapies for macular edema in retinal vein occlusion: A systematic review and network meta-analysis of randomized controlled trials.
    Surv Ophthalmol. 2025 May 24:S0039-6257(25)00096.
    PubMed     Abstract available


  148. KHAN MMH, Akhlaq A, Khan MJ, Ali M, et al
    Impact of social determinants of health on causes of ophthalmic trauma: A narrative review.
    Surv Ophthalmol. 2025 May 24:S0039-6257(25)00091.
    PubMed     Abstract available


  149. RAHMANIPOUR E, Sadeghi E, Arora S, Ghorbani M, et al
    Choroidal hypopigmented lesions: A review.
    Surv Ophthalmol. 2025 May 14:S0039-6257(25)00073.
    PubMed     Abstract available


  150. SINGH SR, Sadeghi E, Vupparaboina KK, Chhablani J, et al
    Recent updates in choroidal imaging biomarkers.
    Surv Ophthalmol. 2025 May 13:S0039-6257(25)00075.
    PubMed     Abstract available


  151. ERDAG M, Citirik M, Dal A
    Augmented and virtual reality in retinal care: A systematic review of their role in training, surgery, and treatment.
    Surv Ophthalmol. 2025 May 10:S0039-6257(25)00072.
    PubMed     Abstract available


  152. CHRONOPOULOS A, Schutz JS, Finger RP
    Prevention of rhegmatogenous retinal detachment.
    Surv Ophthalmol. 2025 May 6:S0039-6257(25)00071.
    PubMed     Abstract available


  153. CIFUENTES-GONZALEZ C, Le Tong Y, Rojas-Carabali W, Mejia-Salgado G, et al
    Systematic Review and meta-analysis: International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) Report 3.
    Surv Ophthalmol. 2025 May 2:S0039-6257(25)00066.
    PubMed     Abstract available


  154. SADEGHI E, Colorado-Zavala MF, Almuhtaseb H, Venkatesh R, et al
    Anatomical and functional changes after internal limiting membrane peeling.
    Surv Ophthalmol. 2025;70:357-368.
    PubMed     Abstract available


  155. CHOPRA P, Fatima A, Mohapatra S, Murugaiyan K, et al
    Extracellular vesicles in dry eye disease and Sjogren's syndrome: A systematic review on their diagnostic and therapeutic role.
    Surv Ophthalmol. 2025;70:499-515.
    PubMed     Abstract available


    April 2025
  156. TAN JK, Steel DH, Ahmad S, Viswanathan A, et al
    Exploring the potential of Rho kinase inhibitors in ophthalmology: From mechanisms to clinical practice.
    Surv Ophthalmol. 2025 Apr 16:S0039-6257(25)00058.
    PubMed     Abstract available


  157. GRASSMEYER JJ, Pennesi ME, Yang P, Tschetter W, et al
    Effects of medications on the human electroretinogram: A comprehensive review.
    Surv Ophthalmol. 2025 Apr 12:S0039-6257(25)00067.
    PubMed     Abstract available


  158. UCAR F
    Comment on: "Postoperative complications of intrascleral intraocular lens fixation: A systematic review and meta-analysis".
    Surv Ophthalmol. 2025 Apr 3:S0039-6257(25)00065.
    PubMed    


    March 2025
  159. MASTROGIUSEPPE E, Alisi L, Romaniello A, Caterino L, et al
    Managing Cutibacterium acnes endophthalmitis after cataract surgery: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Mar 29:S0039-6257(25)00061.
    PubMed     Abstract available


  160. AGARWAL A, Vempuluru VS, Kaliki S
    Primary Ocular, Adnexal, and Orbital Rhabdomyosarcoma: A Review.
    Surv Ophthalmol. 2025 Mar 27:S0039-6257(25)00060.
    PubMed     Abstract available


  161. HUNG JH, Jain T, Khatri A, Nguyen TB, et al
    Inherited retinal diseases-associated uveitis.
    Surv Ophthalmol. 2025 Mar 27:S0039-6257(25)00057.
    PubMed     Abstract available


  162. SHAIKH N, Kumawat D, Chandra P, Senthil S, et al
    Glaucoma in retinopathy of prematurity - A review.
    Surv Ophthalmol. 2025 Mar 25:S0039-6257(25)00056.
    PubMed     Abstract available


  163. SIT AJ, Aihara M, Khawaja AP, Lin SC, et al
    Clinical implications of lowering episcleral venous pressure in the management of glaucoma and the use of Rho kinase inhibitors.
    Surv Ophthalmol. 2025 Mar 17:S0039-6257(25)00052.
    PubMed     Abstract available


  164. GHALEB R, Sallam AB, Grigorian F, Phillips PH, et al
    Oral fluorescein angiography in pediatric ophthalmology.
    Surv Ophthalmol. 2025 Mar 13:S0039-6257(25)00051.
    PubMed     Abstract available


  165. CHEN Y, Jiang F, Zeng Y, Zhang M, et al
    The role of retinal pigment epithelial senescence and the potential of senotherapeutics in age-related macular degeneration.
    Surv Ophthalmol. 2025 Mar 13:S0039-6257(25)00053.
    PubMed     Abstract available


  166. YAO A, Hussain A, Kannan R, Nduka C, et al
    Dynamic procedures for eyelid involvement in facial nerve palsy.
    Surv Ophthalmol. 2025 Mar 13:S0039-6257(25)00054.
    PubMed     Abstract available


  167. RODRIGUEZ-GARCIA A, Ruiz-Lozano RE, Barcelo-Canton RH, Marines-Sanchez HM, et al
    The Etiologic and Pathogenic Spectrum of Exposure Keratopathy: Diagnostic and Therapeutic Implications.
    Surv Ophthalmol. 2025 Mar 8:S0039-6257(25)00050.
    PubMed     Abstract available


  168. RICKELS KL, Ghaleb R, Elhusseiny AM, Chauhan MZ, et al
    Ocular manifestations secondary to cocaine abuse.
    Surv Ophthalmol. 2025 Mar 5:S0039-6257(25)00032.
    PubMed     Abstract available


  169. NEFFENDORF JE, Jackson TL
    Presumed phototoxicity from macular vital staining with Brilliant Blue G and Trypan Blue: A post-market surveillance study, systematic review, and synthesis of the literature.
    Surv Ophthalmol. 2025;70:339-351.
    PubMed     Abstract available


  170. LEI Y, Wang Y, Tang S, Yang J, et al
    The adaptive immune system in the retina of diabetics.
    Surv Ophthalmol. 2025;70:241-254.
    PubMed     Abstract available


  171. BHATTI MT, Fors DH, Muminovic I, Robbins SL, et al
    Heavy duty.
    Surv Ophthalmol. 2025;70:352-355.
    PubMed     Abstract available


  172. ZHANG Q, Wang S, Wang X, Xu C, et al
    Advancing Ophthalmology With Large Language Models: Applications, Challenges, and Future Directions.
    Surv Ophthalmol. 2025 Mar 1:S0039-6257(25)00037.
    PubMed     Abstract available


    February 2025
  173. DUNNIGAN JK, Wang CY, George L, Lee VA, et al
    Social Media in Ophthalmology: A Comprehensive Literature Review.
    Surv Ophthalmol. 2025 Feb 22:S0039-6257(25)00031.
    PubMed     Abstract available


  174. GHAFARIAN S, Samavat B, Lee K, Sheikhghomi S, et al
    Clinical strategies to prevent recurrence of Herpes simplex and Herpes zoster following ocular surgery: A comprehensive review with practical guidelines.
    Surv Ophthalmol. 2025 Feb 15:S0039-6257(25)00029.
    PubMed     Abstract available


  175. AL-DABET S, Turaev S, Zaki N
    Ocular-Induced Abnormal Head Postures: A Systematic Review and Analysis.
    Surv Ophthalmol. 2025 Feb 9:S0039-6257(25)00021.
    PubMed     Abstract available


  176. ZHANG C, Lai D, Zhu D, Palka C, et al
    Chlorhexidine for ocular antisepsis before intravitreal injection: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Feb 6:S0039-6257(25)00024.
    PubMed     Abstract available


  177. CIFUENTES-GONZALEZ C, Le Tong Y, Mejia-Salgado G, Chan R, et al
    Global demographic and etiological variations of retinal vasculitis: A systematic review and meta-analysis: International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) Report 1.
    Surv Ophthalmol. 2025 Feb 5:S0039-6257(25)00023.
    PubMed     Abstract available


    January 2025
  178. YANG Z, Tian D, Xie Z, Cheng T, et al
    Clinical features, diagnosis, management, and prognosis of circumscribed choroidal hemangioma.
    Surv Ophthalmol. 2025 Jan 23:S0039-6257(25)00011.
    PubMed     Abstract available


  179. SADEGHI E, Rahmanipour E, Valsecchi N, Kapoor S, et al
    An update on ocular effects of antidiabetic medications.
    Surv Ophthalmol. 2025 Jan 22:S0039-6257(25)00019.
    PubMed     Abstract available


  180. TURCAS C, Nicoara SD
    A comprehensive review of structure-function correlations in age-related macular degeneration: Contributions of microperimetry.
    Surv Ophthalmol. 2025 Jan 17:S0039-6257(25)00017.
    PubMed     Abstract available


  181. ORTIZ-MORALES G, Ruiz-Lozano RE, Morales-Mancillas N, Homar Paez-Garza J, et al
    Pediatric blepharokeratoconjunctivitis: A challenging ocular surface disease.
    Surv Ophthalmol. 2025 Jan 17:S0039-6257(25)00009.
    PubMed     Abstract available


  182. BAYAT K, Pooyan P, Looha MA, Namakin K, et al
    Retinal structural alterations in patients with epilepsy taking antiepileptic drugs: A systematic review and meta-analysis of OCT findings.
    Surv Ophthalmol. 2025 Jan 15:S0039-6257(25)00012.
    PubMed     Abstract available


  183. FORTE P, Paques M, Cattaneo J, Dupas B, et al
    Perifoveal vascular anomalous complex and telangiectatic capillaries: An overview of two entities potentially sharing a common pathophysiology.
    Surv Ophthalmol. 2025 Jan 15:S0039-6257(25)00014.
    PubMed     Abstract available


  184. FEO A, Stradiotto E, Govetto A, Forte P, et al
    Bacillary layer detachment: Updates on its clinical and prognostic significance in retinal disease.
    Surv Ophthalmol. 2025 Jan 14:S0039-6257(25)00013.
    PubMed     Abstract available


  185. DE LOTT LB, Kaplan C, Harte S, Clauw DJ, et al
    Nociplastic pain among individuals with chronic ocular surface pain: one cause for "pain without stain"?
    Surv Ophthalmol. 2025 Jan 13:S0039-6257(25)00015.
    PubMed     Abstract available


  186. LIU T, Elnahry AG, Tauqeer Z, Yu Y, et al
    Incidence and risk factors of perioperative suprachoroidal hemorrhage: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025;70:54-62.
    PubMed     Abstract available


  187. YANG W, Ren R, Xie Y, Wang J, et al
    Diabetic uveopathy.
    Surv Ophthalmol. 2025;70:47-53.
    PubMed     Abstract available


  188. BHATTI MT, Long JR, Carey AR
    Denial.
    Surv Ophthalmol. 2025;70:162-166.
    PubMed     Abstract available


    December 2024
  189. LIN TH, Lin HY, Tseng PC
    Enhancing anti-vascular endothelial growth factor with photodynamic therapy for polypoidal choroidal vasculopathy: A meta-analysis.
    Surv Ophthalmol. 2024 Dec 19:S0039-6257(24)00157.
    PubMed     Abstract available


  190. NGOC VAN ANH L, Ngoc Cong N, Ngamjit K, Usanee R, et al
    Penetrating keratoplasty versus deep anteriror lamellar keratoplasty for macular corneal dystrophy: A meta-analysis.
    Surv Ophthalmol. 2024 Dec 19:S0039-6257(24)00156.
    PubMed     Abstract available


  191. SERVILLO A, Scandale P, Oldoni G, Begar PG, et al
    Inflammatory choroidal neovascularization: An evidence-based update.
    Surv Ophthalmol. 2024 Dec 18:S0039-6257(24)00155.
    PubMed     Abstract available


  192. JIRAVARNSIRIKUL A, Belghith A, Rezapour J, Bowd C, et al
    Evaluating glaucoma in myopic eyes: Challenges and opportunities.
    Surv Ophthalmol. 2024 Dec 17:S0039-6257(24)00154.
    PubMed     Abstract available


  193. SANTINA A, Feo A, Bousquet E, Velaga SB, et al
    Pentosan polysulfate sodium maculopathy: Final analysis of a prospective cohort, updated review, and association with inflammatory bowel disease.
    Surv Ophthalmol. 2024 Dec 12:S0039-6257(24)00153.
    PubMed     Abstract available


  194. NAGINO K, Inomata T, Ohta T, Sung J, et al
    Postoperative complications of intrascleral intraocular lens fixation: A systematic review and meta-analysis.
    Surv Ophthalmol. 2024 Dec 12:S0039-6257(24)00152.
    PubMed     Abstract available


    November 2024
  195. EIJGEN JV, Winckel LV, Hanssen H, Kotliar K, et al
    Retinal vessel analysis to assess microvascular function in the healthy eye: A systematic review on the response to acute physiological and pathological stressors.
    Surv Ophthalmol. 2024 Nov 24:S0039-6257(24)00140.
    PubMed     Abstract available


  196. RAI BB, Maddess T, Nolan CJ
    Functional diabetic retinopathy: A new concept to improve management of diabetic retinal diseases.
    Surv Ophthalmol. 2024 Nov 23:S0039-6257(24)00142.
    PubMed     Abstract available


  197. ISSA M, Sukkarieh G, Gallardo M, Sarbout I, et al
    Applications of artificial intelligence to inherited retinal diseases: A systematic review.
    Surv Ophthalmol. 2024 Nov 18:S0039-6257(24)00139.
    PubMed     Abstract available


  198. LEE SJV, FRCOphth, Goh YQ, Rojas-Carabali W, et al
    Association between retinal vessels caliber and systemic health: A comprehensive review.
    Surv Ophthalmol. 2024 Nov 16:S0039-6257(24)00138.
    PubMed     Abstract available


  199. VAHEB S, Panah MY, Shaygannejad V, Zabeti A, et al
    Uveitis among people with multiple sclerosis: A systematic review and meta-analysis.
    Surv Ophthalmol. 2024 Nov 15:S0039-6257(24)00134.
    PubMed     Abstract available


  200. PUTERA I, Distia Nora R, Dewi AC, Suhada DS, et al
    Antiviral therapy for cytomegalovirus retinitis: A systematic review and meta-analysis.
    Surv Ophthalmol. 2024 Nov 14:S0039-6257(24)00141.
    PubMed     Abstract available


  201. RIZZO C, Savastano MC, Kilian R, Marchini G, et al
    Structural en face optical coherence tomography in neovascular and nonneovascularage-related macular degeneration: Use and utility in clinical practice.
    Surv Ophthalmol. 2024 Nov 8:S0039-6257(24)00135.
    PubMed     Abstract available


  202. LI L, Xiao K, Shang X, Hu W, et al
    Advances in artificial intelligence for meibomian gland evaluation: A comprehensive review.
    Surv Ophthalmol. 2024;69:945-956.
    PubMed     Abstract available


    October 2024
  203. ELSAYED MEA, Lander B, Senthil S, Edward DP, et al
    The Secondary Childhood Glaucomas.
    Surv Ophthalmol. 2024 Oct 30:S0039-6257(24)00132.
    PubMed     Abstract available


  204. SADEGHI E, Valsecchi N, Rahmanipour E, Ejlalidiz M, et al
    Choroidal biomarkers in age-related macular degeneration.
    Surv Ophthalmol. 2024 Oct 17:S0039-6257(24)00131.
    PubMed     Abstract available


  205. ALBRECHT M, Auffarth GU, Friedrich M, Kessler LJ, et al
    Vision degrading myodesopsia from vitreous floaters in the young: An important aspect of myopia.
    Surv Ophthalmol. 2024 Oct 16:S0039-6257(24)00128.
    PubMed     Abstract available


  206. NEWMAN NJ, Biousse V, Yu-Wai-Man P, Carelli V, et al
    Meta-analysis of treatment outcomes for patients with m.11778G>A MT-ND4 Leber Hereditary Optic Neuropathy.
    Surv Ophthalmol. 2024 Oct 15:S0039-6257(24)00130.
    PubMed     Abstract available


  207. GUPTA Y, Devi C, Priyadarshini K, Mandal S, et al
    Pediatric Keratoconus.
    Surv Ophthalmol. 2024 Oct 11:S0039-6257(24)00129.
    PubMed     Abstract available


  208. HOVEN E, Michelet JT, Vettore MV, Lagali N, et al
    Choroidal thickness after anti-VEGF in typical neovascular age-related macular degeneration - A systematic review and meta-analysis.
    Surv Ophthalmol. 2024 Oct 5:S0039-6257(24)00124.
    PubMed     Abstract available


    September 2024
  209. MIKHAIL D, Milad D, Antaki F, Hammamji K, et al
    The role of artificial intelligence in macular hole management: A scoping review.
    Surv Ophthalmol. 2024 Sep 30:S0039-6257(24)00123.
    PubMed     Abstract available


  210. BERMAN G, Pendley AM, Wright DW, Silverman R, et al
    Breaking the barriers: Methodology of implementation of a non-mydriatic ocular fundus camera in an emergency department.
    Surv Ophthalmol. 2024 Sep 30:S0039-6257(24)00127.
    PubMed     Abstract available


  211. TAN JCK, Yohannan J, Ramulu PY, Kalloniatis M, et al
    Visual field testing in glaucoma using the Swedish Interactive Threshold Algorithm.
    Surv Ophthalmol. 2024 Sep 28:S0039-6257(24)00118.
    PubMed     Abstract available


  212. STALHAMMAR G, Hagstrom A, Ermedahl Conradi M, Williams PA, et al
    Choroidal nevi and melanoma doubling times and implications for delays in treatment: A systematic review and meta-analysis.
    Surv Ophthalmol. 2024 Sep 28:S0039-6257(24)00117.
    PubMed     Abstract available


  213. ALISI L, Giovannetti F, Armentano M, Lucchino L, et al
    Challenging corneal diseases and miRNA expression: Focus on rare diseases and new therapeutic frontiers.
    Surv Ophthalmol. 2024 Sep 27:S0039-6257(24)00120.
    PubMed     Abstract available


  214. FERRO DESIDERI L, Sim PY, Bernardi E, Paschon K, et al
    Evidence-based guidelines for drug dosing in intravitreal injections in silicone oil-filled eyes: Pharmacokinetics, safety, and optimal dosage.
    Surv Ophthalmol. 2024 Sep 27:S0039-6257(24)00119.
    PubMed     Abstract available


  215. D'ALBENZIO A, Komici K, Affatato M, Castelluzzo AM, et al
    Vitreous Cortex Remnants in Patients With Rhegmatogenous Retinal Detachment: A Systematic Review and Meta-analysis.
    Surv Ophthalmol. 2024 Sep 26:S0039-6257(24)00121.
    PubMed     Abstract available


  216. LEI C, Lv Z, Hua R, Duan J, et al
    Focal choroidal excavation: Review and updated pathogenesis.
    Surv Ophthalmol. 2024 Sep 25:S0039-6257(24)00126.
    PubMed     Abstract available


  217. YANG Q, Ju G, He Y
    Corneal densitometry: New evaluation indicator for corneal diseases.
    Surv Ophthalmol. 2024 Sep 24:S0039-6257(24)00122.
    PubMed     Abstract available


  218. WANG K, Liu Y, Li S, Zhao N, et al
    Unveiling the therapeutic potential and mechanisms of stanniocalcin-1 in retinal degeneration.
    Surv Ophthalmol. 2024 Sep 11:S0039-6257(24)00085.
    PubMed     Abstract available


  219. SUH A, Ditelberg S, Szeto JJ, Kumar D, et al
    Safety protocols, precautions, and countermeasures aboard the International Space Station (ISS) to prevent ocular injury.
    Surv Ophthalmol. 2024 Sep 3:S0039-6257(24)00097.
    PubMed     Abstract available


  220. L'ABBATE D, Prescott K, Geraghty B, Kearns VR, et al
    Biomechanical considerations for optimising subretinal injections.
    Surv Ophthalmol. 2024;69:722-732.
    PubMed     Abstract available


  221. TAWFIK HA, Ali MJ
    A major review on punctal stenosis: Part II: Updated therapeutic interventions, complications, and outcomes.
    Surv Ophthalmol. 2024;69:756-768.
    PubMed     Abstract available


  222. BIRCH EE, Duffy KR
    Leveraging neural plasticity for the treatment of amblyopia.
    Surv Ophthalmol. 2024;69:818-832.
    PubMed     Abstract available


  223. CHEN JS, Korn BS, Carey AR, Savino PJ, et al
    Looking beyond blurred margins.
    Surv Ophthalmol. 2024;69:842-846.
    PubMed     Abstract available


    August 2024
  224. CHAUHAN K, Dave VP, de Ribot FM, Agrawal R, et al
    Traumatic retinal detachment: A contemporary update.
    Surv Ophthalmol. 2024 Aug 31:S0039-6257(24)00101.
    PubMed     Abstract available


  225. MANO F, LoBue S, Tailor P, Olsen TW, et al
    Incisional choroidal surgery.
    Surv Ophthalmol. 2024 Aug 31:S0039-6257(24)00096.
    PubMed     Abstract available


  226. JESSUP AJC, Coroneo MT
    Examining the fabric of the eye: Antoni van Leeuwenhoek, the draper and ocular microscopist.
    Surv Ophthalmol. 2024 Aug 28:S0039-6257(24)00098.
    PubMed     Abstract available


  227. ZHAO Q, Wei L, Chen Y
    Detection of choroidal vascular features in diabetic patients without clinically visible diabetic retinopathy by optical coherence tomography angiography: A systemic review and meta-analysis.
    Surv Ophthalmol. 2024 Aug 28:S0039-6257(24)00100.
    PubMed     Abstract available


  228. SURICO PL, Barone V, Singh RB, Coassin M, et al
    Potential applications of mesenchymal stem cells in ocular surface immune-mediated disorders.
    Surv Ophthalmol. 2024 Aug 1:S0039-6257(24)00083.
    PubMed     Abstract available


  229. SCHLOESSER L, Klose SM, Mauschitz MM, Abdullah Z, et al
    The role of immune modulators in age-related macular degeneration.
    Surv Ophthalmol. 2024 Aug 1:S0039-6257(24)00084.
    PubMed     Abstract available


    July 2024
  230. MARMOR MF
    Lupus review is misleading about risk of hydroxychloroquine retinal toxicity.
    Surv Ophthalmol. 2024 Jul 24:S0039-6257(24)00082.
    PubMed    


  231. ZHANG Z, Shan X, Li S, Chang J, et al
    Retinal light damage: From mechanisms to protective strategies.
    Surv Ophthalmol. 2024 Jul 23:S0039-6257(24)00079.
    PubMed     Abstract available


  232. VUJOSEVIC S, Lupidi M, Donati S, Astarita C, et al
    Role of inflammation in diabetic macular edema and neovascular age-related macular degeneration.
    Surv Ophthalmol. 2024 Jul 17:S0039-6257(24)00080.
    PubMed     Abstract available


  233. FOUAD YA, Cicinelli MV, Marchese A, Casalino G, et al
    Revisiting acute retinal pigment epitheliitis (Krill disease).
    Surv Ophthalmol. 2024 Jul 16:S0039-6257(24)00078.
    PubMed     Abstract available


  234. TORKASHVAND A, Izadian A, Hajrasouliha A
    Advances in Ophthalmic Therapeutic Delivery: A Comprehensive Overview of Present and Future Directions.
    Surv Ophthalmol. 2024 Jul 8:S0039-6257(24)00076.
    PubMed     Abstract available


  235. HASHEMI E, Looha MA, Mazaherinia H, Samadaeian N, et al
    Risk of stroke development following retinal vein occlusion: A systematic review and meta-analysis.
    Surv Ophthalmol. 2024 Jul 3:S0039-6257(24)00074.
    PubMed     Abstract available


  236. SINCLAIR SH, Schwartz S
    Diabetic retinopathy: New concepts of screening, monitoring, and interventions.
    Surv Ophthalmol. 2024 Jul 2:S0039-6257(24)00077.
    PubMed     Abstract available


  237. WU H, Jin K, Yip CC, Koh V, et al
    A systematic review of economic evaluation of artificial intelligence-based screening for eye diseases: From possibility to reality.
    Surv Ophthalmol. 2024;69:499-507.
    PubMed     Abstract available


  238. BUNJO LJ, Bacchi S, Pietris J, Chan WO, et al
    Current management options for the treatment of refractory postoperative cystoid macular edema: A systematic review.
    Surv Ophthalmol. 2024;69:606-621.
    PubMed     Abstract available


  239. LEIDY L, Dickinson A, Ramulu P, Ehrlich J, et al
    Clinical outcome measures in vision and eye care.
    Surv Ophthalmol. 2024;69:632-637.
    PubMed     Abstract available


    June 2024
  240. HOSSEINI F, Asadi F, Rabiei R, Kiani F, et al
    Applications of artificial intelligence in diagnosis of uncommon cystoid macular edema using optical coherence tomography imaging: A systematic review.
    Surv Ophthalmol. 2024 Jun 26:S0039-6257(24)00073.
    PubMed     Abstract available


  241. PARRAVANO M, Cennamo G, Di Antonio L, Grassi MO, et al
    Multimodal imaging in diabetic retinopathy and macular edema: An update about biomarkers.
    Surv Ophthalmol. 2024 Jun 26:S0039-6257(24)00075.
    PubMed     Abstract available


  242. DAUNGSUPAWONG H, Wiwanitkit V
    Generative artificial intelligence in ophthalmology: Correspondence.
    Surv Ophthalmol. 2024 Jun 17:S0039-6257(24)00071.
    PubMed    


  243. FARAHAT Z, Zrira N, Souissi N, Bennani Y, et al
    Diabetic retinopathy screening through artificial intelligence algorithms: A systematic review.
    Surv Ophthalmol. 2024 Jun 15:S0039-6257(24)00051.
    PubMed     Abstract available


  244. POSARELLI M, Passaro ML, Avolio FC, Costagliola C, et al
    The incidence of severe complications in acanthamoeba keratitis: Qualitative and quantitative systematic assessment.
    Surv Ophthalmol. 2024 Jun 15:S0039-6257(24)00069.
    PubMed     Abstract available


  245. WAISBERG E, Ong J, Masalkhi M, Lee AG, et al
    Future directions of generative artificial intelligence in ophthalmology and vision science.
    Surv Ophthalmol. 2024 Jun 14:S0039-6257(24)00072.
    PubMed    


    May 2024
  246. BACHMEIER I, Armendariz BG, Yu S, Jager RJ, et al
    Corrigendum to "Fibrosis in neovascular age-related macular degeneration: a review of definitions based on clinical imaging" [Surv Ophthalmol 68 (2023) 835-848/5].
    Surv Ophthalmol. 2024 May 28:S0039-6257(23)00137.
    PubMed    


  247. HERNANDEZ RF, Rodriguez JEM, Trecu MS, Tariq Bhatti M, et al
    Not everything is ischemic optic neuropathy.
    Surv Ophthalmol. 2024 May 23:S0039-6257(24)00054.
    PubMed     Abstract available


  248. VEMPULURU VS, Maniar A, Bakal K, Kaliki S, et al
    Role of MYCN in Retinoblastoma: A Review of Current Literature.
    Surv Ophthalmol. 2024 May 23:S0039-6257(24)00055.
    PubMed     Abstract available


  249. CHENG T, Gu X, Yang Z, Wang C, et al
    Clinical features of ocular damage in systemic lupus erythematosus and risk factors of hydroxychloroquine related complications.
    Surv Ophthalmol. 2024 May 21:S0039-6257(24)00052.
    PubMed     Abstract available


  250. KNECHT KT, Chiriac G, Guan HD
    The potential impact of a vegetarian diet on glaucoma.
    Surv Ophthalmol. 2024 May 18:S0039-6257(24)00048.
    PubMed     Abstract available


  251. WAISBERG E, Ong J, Kamran SA, Masalkhi M, et al
    Generative artificial intelligence in ophthalmology.
    Surv Ophthalmol. 2024 May 16:S0039-6257(24)00044.
    PubMed     Abstract available


  252. FEKRAZAD S, Hassanzadeh G, Salehi MA, Mozafar M, et al
    Optical coherence tomography angiography measurements in systemic lupus erythematosus: A systematic review and meta-analysis.
    Surv Ophthalmol. 2024 May 12:S0039-6257(24)00047.
    PubMed     Abstract available


  253. TRINCAO-MARQUES TM, Ayton LN, Hickey DG, Marques-Neves C, et al
    Gene and cell therapy for age-related macular degeneration: A review.
    Surv Ophthalmol. 2024 May 10:S0039-6257(24)00049.
    PubMed     Abstract available


  254. NIAZI S, Doroodgar F, Nazari SH, Rahimi Y, et al
    Refractive surgical approaches to keratoconus: A systematic review and network meta-analysis.
    Surv Ophthalmol. 2024 May 4:S0039-6257(24)00045.
    PubMed     Abstract available


  255. TAWFIK HA, Ali MJ
    A major review of punctal stenosis: Updated anatomy, epidemiology, etiology, and clinical presentation.
    Surv Ophthalmol. 2024;69:441-455.
    PubMed     Abstract available


  256. HUANG RS, Mihalache A, Popovic MM, Cruz-Pimentel M, et al
    Diagnostic methods for primary vitreoretinal lymphoma: A systematic review.
    Surv Ophthalmol. 2024;69:456-464.
    PubMed     Abstract available


  257. ROY R, Chattree S, Kala U, Majumdar B, et al
    Multicolor imaging: Current clinical applications.
    Surv Ophthalmol. 2024;69:378-402.
    PubMed     Abstract available


  258. ARORA S, Zur D, Iovino C, Chhablani J, et al
    Peripapillary fluid: Obvious and not so obvious!
    Surv Ophthalmol. 2024;69:311-329.
    PubMed     Abstract available


  259. PELLEGRINI F, Basciu M, Foroozan R
    Planet of the apex.
    Surv Ophthalmol. 2024;69:495-498.
    PubMed     Abstract available


    April 2024
  260. VERA-DUARTE GR, Jimenez-Collado D, Kahuam-Lopez N, Ramirez-Miranda A, et al
    Neurotrophic keratopathy: General features and new therapies.
    Surv Ophthalmol. 2024 Apr 26:S0039-6257(24)00042.
    PubMed     Abstract available


  261. LEE YM, Bahrami B, Selva D, Casson RJ, et al
    Scoping review of non-surgical treatment options for macular holes.
    Surv Ophthalmol. 2024 Apr 25:S0039-6257(24)00043.
    PubMed     Abstract available


  262. KANG C, Lee MJ, Chomsky A, Oetting TA, et al
    Risk factors for complications in resident-performed cataract surgery: A systematic review.
    Surv Ophthalmol. 2024 Apr 20:S0039-6257(24)00032.
    PubMed     Abstract available


  263. SALEHI MA, Frounchi N, Zakavi SS, Mohammadi S, et al
    Retinal and choroidal changes after anti-VEGF therapy in Neovascular-AMD Patients: A Systematic Review and Meta-Analysis of SD-OCT studies.
    Surv Ophthalmol. 2024 Apr 17:S0039-6257(24)00033.
    PubMed     Abstract available


  264. KROLO I, Behaegel J, Termote K, de Bruyn B, et al
    The role of topical insulin on ocular surface restoration: A review.
    Surv Ophthalmol. 2024 Apr 10:S0039-6257(24)00031.
    PubMed     Abstract available


    March 2024
  265. ARDA H, Maier M, Schultheiss M, Haritoglou C, et al
    Advances in management strategies for large and persistent macular hole: an update.
    Surv Ophthalmol. 2024 Mar 27:S0039-6257(24)00030.
    PubMed     Abstract available


  266. NOURI H, Abtahi SH, Mazloumi M, Samadikhadem S, et al
    Optical coherence tomography angiography in diabetic retinopathy: A major review.
    Surv Ophthalmol. 2024 Mar 21:S0039-6257(24)00021.
    PubMed     Abstract available


  267. BRESSLER NM, Kaiser PK, Do DV, Nguyen QD, et al
    Biosimilars of anti-vascular endothelial growth factor for ophthalmic diseases: A review.
    Surv Ophthalmol. 2024 Mar 21:S0039-6257(24)00029.
    PubMed     Abstract available


  268. SCHEFFER M, Menting J, Boeije H, van Nispen R, et al
    Understanding healthcare communication in age-related macular degeneration care: A mixed-methods review of patients' perspectives.
    Surv Ophthalmol. 2024 Mar 16:S0039-6257(24)00018.
    PubMed     Abstract available


  269. SABATINO F, Banerjee P, K Muqit MM
    Clinical therapeutics for proliferative vitreoretinopathy in retinal detachment.
    Surv Ophthalmol. 2024 Mar 15:S0039-6257(24)00024.
    PubMed     Abstract available


  270. ANG T, Chaggar V, Tong JY, Selva D, et al
    Medication-associated orbital inflammation: A systematic review.
    Surv Ophthalmol. 2024 Mar 13:S0039-6257(24)00020.
    PubMed     Abstract available


  271. ORTIZ-SELLER A, Martorell P, Barranco H, Pascual-Camps I, et al
    Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis.
    Surv Ophthalmol. 2024 Mar 1:S0039-6257(24)00008.
    PubMed     Abstract available


  272. OO HH, Mohan M, Song W, Rojas-Carabali W, et al
    Anterior chamber inflammation grading methods: A critical review.
    Surv Ophthalmol. 2024;69:253-264.
    PubMed     Abstract available


  273. YESILTAS YS, Oakey Z, Wrenn J, Yeaney G, et al
    Uveal melanoma in African Americans: Diagnostic challenges.
    Surv Ophthalmol. 2024;69:190-197.
    PubMed     Abstract available


  274. ARNOLD RW
    Surgical and anesthetic influences of the oculocardiac reflex in adults and children during strabismus surgery.
    Surv Ophthalmol. 2024;69:295.
    PubMed    


  275. ROBBINS SL, Greenberg M, Juan I
    Surgical and anesthetic influences of the oculocardiac reflex in adults and children during strabismus surgery.
    Surv Ophthalmol. 2024;69:S0039-625700087-5.
    PubMed    


    February 2024
  276. JIANG F, Lei C, Chen Y, Zhou N, et al
    The complement system and diabetic retinopathy.
    Surv Ophthalmol. 2024 Feb 23:S0039-6257(24)00007.
    PubMed     Abstract available


    September 2023
  277. PELLEGRINI F, Basciu M, Falardeau J
    Pole to pole.
    Surv Ophthalmol. 2023;68:1002-1005.
    PubMed     Abstract available


  278. MA F, Yuan M, Kozak I
    Multispectral imaging: Review of current applications.
    Surv Ophthalmol. 2023;68:889-904.
    PubMed     Abstract available


  279. WOUDSTRA-DE JONG JE, Manning-Charalampidou SS, Vingerling H, Busschbach JJ, et al
    Patient-reported outcomes in patients with vitreous floaters: A systematic literature review.
    Surv Ophthalmol. 2023;68:875-888.
    PubMed     Abstract available


  280. TONG JY, Huilgol SC, James C, Selva D, et al
    Recommendations for risk stratification of periocular squamous cell carcinoma.
    Surv Ophthalmol. 2023;68:964-976.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ophthalmology is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum